文献速递腹部MR

LI-RADS v2018:在钆塞酸增强MRI上如何恰当使用辅助特征将中等恶性概率(LR-3)调整为很可能HCC(LR-4)

LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI.
PubMed 文献 · Eur Radiol · 2021-06-16

回顾性分析252例患者336个肝脏结节(191个HCC,145个非恶性)的钆塞酸增强MRI,评估LI-RADS辅助特征在LR-3升级为LR-4中的使用。仅用T2轻中度高信号升级时敏感度53.9%、特异度75.9%,使用任何恶性辅助特征时敏感度88.5%、特异度21.4%。作者认为T2轻中度高信号可能更适合用于LR-3升级为LR-4。

要点

  • 基于LI-RADS诊断表为LR-3的观察中,T2轻中度高信号是HCC而非非恶性结节的独立预测因子(OR=3.01,p=0.002)。
  • 仅用T2高信号将LR-3升级为LR-4时,HCC诊断敏感度53.9%(103/191)、特异度75.9%(110/145)。
  • 使用任何支持恶性的辅助特征升级时,敏感度88.5%(169/191)、特异度21.4%(31/145),特异度显著下降。

核心结论

  • 应用MRI辅助特征进行LI-RADS分类调整可提高LR-4对HCC诊断的敏感度,但伴随特异度显著下降;T2轻中度高信号这一提示HCC的辅助特征可能更适合用于LR-3升级为LR-4。

研究设计与样本

  • 回顾性分析252例患者336个实性肝脏结节(≤30 mm)的钆塞酸增强MRI特征,结节按LI-RADS分为LR-3或LR-4。

关键影像表现/征象

  • 基于主要HCC特征,248个结节(123个HCC)归为表基LR-3,88个结节(68个HCC)归为表基LR-4。
  • 在表基LR-3观察中,T2轻中度高信号被识别为HCC而非非恶性结节的独立预测因子(OR=3.01,p=0.002)。

诊断标准与关键数值

  • 仅表基LR-4标准:HCC诊断敏感度35.6%(68/191)、特异度86.2%(125/145)。
  • 仅用T2高信号允许升级:敏感度53.9%(103/191)、特异度75.9%(110/145)。
  • 使用任何支持恶性的辅助特征升级:敏感度88.5%(169/191)、特异度21.4%(31/145);三种标准间差异均有统计学意义(均p<0.001)。

临床应用与阅片要点

  • 作者认为,T2轻中度高信号这一显著提示HCC的辅助特征可能更适合用于将LR-3升级为LR-4。
  • 使用任何支持恶性的辅助特征升级LR-3至LR-4时,LR-4对HCC诊断的敏感度增加但特异度下降。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the appropriate use of ancillary features (AFs) in upgrading LI-RADS category 3 (LR-3) to category 4 (LR-4) for hepatic nodules on gadoxetic acid-enhanced MRI.

METHODS: We retrospectively analyzed MRI features of solid hepatic nodules (≤ 30 mm) categorized as LR-3/4 on gadoxetic acid-enhanced MRI. In LI-RADS diagnostic table-based-LR-3 observations, logistic regression analyses were performed to identify AFs suggestive of hepatocellular carcinomas (HCCs) rather than non-malignant nodules. Using McNemar's test, the sensitivities and specificities of the final-LR-4 category for HCC diagnosis were compared according to the principles of AF application in category adjustment.

RESULTS: A total of 336 hepatic nodules (191 HCCs; 145 non-malignant) in 252 patients were evaluated. Based on major HCC features, 248 nodules (123 HCCs) were assigned as table-based-LR-3 and 88 nodules (68 HCCs) as table-based-LR-4. In table-based-LR-3 observations, mild-moderate T2 hyperintensity was identified as an independent predictor of HCC as opposed to non-malignant nodules (odds ratio = 3.01, p = 0.002). For HCC diagnosis, different criteria of final-LR-4: only table-based-LR-4, allowing category upgrade using only T2 hyperintensity, or using any AFs favoring malignancy resulted in sensitivities of 35.6% (68/191), 53.9% (103/191), and 88.5% (169/191), and specificities of 86.2% (125/145), 75.9% (110/145), and 21.4% (31/145), respectively, which differed from each other (all p < 0.001).

CONCLUSIONS: While the application of MRI AF in LI-RADS category adjustment increases the sensitivity of LR-4 category for HCC diagnosis, it is accompanied by a significant decrease in specificity. Mild-moderate T2 hyperintensity, a significant AF indicative of HCC, may be more appropriate for upgrading LR-3 to LR-4.

KEY POINTS: • When upgrading from LR-3 to LR-4 using any MRI ancillary features favoring malignancy, LR-4 sensitivity increases but specificity decreased for HCC diagnosis. • By upgrading LR-3 to LR-4 based on MRI ancillary features found to suggest HCC rather than non-malignant nodules in multivariate analysis (i.e., mild-moderate T2 hyperintensity), LR-4 demonstrated a more balanced sensitivity and specificity for HCC diagnosis (53.9% and 75.9%, respectively).

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Jeon SK, Joo I, Bae JS, et al. LI-RADS v2018: how to appropriately use ancillary features in category adjustment from intermediate probability of malignancy (LR-3) to probably HCC (LR-4) on gadoxetic acid-enhanced MRI. Eur Radiol. 2021. PMID: 34132875. doi:10.1007/s00330-021-08116-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。